Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT
Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
This drug has eigthy-two patent family members in fifteen countries.
The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. One supplier is listed for this compound. Additional details are available on the glycopyrrolate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
